A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine

Clinical trial NCT00833963 · COMPLETED

Trial details

NCT number: NCT00833963
Sponsor: Genentech, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Pregnancy

Start date: 2009-01-14
Primary completion: 2017-04-13
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.